Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5174066 | 1.00 | CYP3A4 (0.35) | CYP3A4TSHRHSD17B10MAPK1ALDH1A1 | |
| SCHEMBL6549315 | 0.90 | ALDH1A1 (0.38) | CYP3A4TSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL6549321 | 0.90 | ALDH1A1 (0.38) | CYP3A4TSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL5438026 | 0.83 | NPC1 (0.37) | CYP3A4TSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL5173935 | 0.83 | NPC1 (0.37) | CYP3A4TSHRHSD17B10ALDH1A1ALOX15 | |
| SCHEMBL5173899 | 0.82 | CASP1 (0.38) | CYP3A4TSHRALDH1A1CASP1RECQL | |
| SCHEMBL5173902 | 0.82 | CASP1 (0.38) | CYP3A4TSHRALDH1A1CASP1RECQL | |
| SCHEMBL5173292 | 0.82 | ADRA2B (0.30) | — | |
| SCHEMBL5437708 | 0.82 | ADRA2B (0.30) | — | |
| SCHEMBL6550255 | 0.81 | CYP3A4 (0.38) | CYP3A4TSHRHSD17B10MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070169287-A1 | P-diaminobenzene derivatives and dyes containing these compounds | THE PROCTER & GAMBLE COMPANY (US) | 2007-07-26 | — | — | US | claimed |
| US-20070169287-A1 | P-diaminobenzene derivatives and dyes containing these compounds | THE PROCTER & GAMBLE COMPANY (US) | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070169287-A1 | P-diaminobenzene derivatives and dyes containing these compounds | KRT18, DSP, DSG1 | CYP3A4 2470/4885TSHR 4826/4885HSD17B10 2107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.